Drug-induced interstitial lung disease.
Spagnolo P, Bonniaud P, Rossi G, Sverzellati N, Cottin V.
Eur Respir J. 2022 Oct 27;60(4):2102776. doi: 10.1183/13993003.02776-2021. Print 2022 Oct.
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment.
Conte P, Ascierto PA, Patelli G, Danesi R, Vanzulli A, Sandomenico F, Tarsia P, Cattelan A, Comes A, De Laurentiis M, Falcone A, Regge D, Richeldi L, Siena S.
ESMO Open. 2022 Apr;7(2):100404. doi: 10.1016/j.esmoop.2022.100404. Epub 2022 Feb 24.
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review.
Tarantino P, Modi S, Tolaney SM, Cortés J, Hamilton EP, Kim SB, Toi M, Andrè F, Curigliano G.
JAMA Oncol. 2021 Dec 1;7(12):1873-1881. doi: 10.1001/jamaoncol.2021.3595.
Drug-induced lung disease: a brief update for radiologists.
Ufuk F, Bayraktaroğlu S, Rüksan Ütebey A.
Diagn Interv Radiol. 2023 Jan 31;29(1):80-90. doi: 10.5152/dir.2022.21614. Epub 2022 Nov 29.
Drug-induced interstitial lung disease: a narrative review of a clinical conundrum.
Harrison M, Kavanagh G, Corte TJ, Troy LK.
Expert Rev Respir Med. 2024 Jan-Feb;18(1-2):23-39. doi: 10.1080/17476348.2024.2329612. Epub 2024 Mar 19.
Drug-induced lung disease: a narrative review.
Bridi GDP, Fonseca EKUN, Kairalla RA, Amaral AF, Baldi BG.
J Bras Pneumol. 2024 Sep 27;50(4):e20240110. doi: 10.36416/1806-3756/e20240110. eCollection 2024.
Drug-induced Lung Disease in the Oncology Patient: From Cytotoxic Agents to Immunotherapy.
Shroff GS, Sheshadri A, Altan M, Truong MT, Erasmus LT, Vlahos I.
Clin Chest Med. 2024 Jun;45(2):325-337. doi: 10.1016/j.ccm.2024.02.006. Epub 2024 Mar 23.
Drug-induced lung disease.
Whitcomb ME.
Chest. 1973 Mar;63(3):418-22. doi: 10.1378/chest.63.3.418.
Drug-induced lung disease.
Cole P.
Drugs. 1977 Jun;13(6):422-44. doi: 10.2165/00003495-197713060-00002.
Drug induced lung disease--amiodarone in focus.
Vasić NR, Milenković BA, Pešut DP, Stević RS, Jovanović DM.
Med Pregl. 2014 Sep-Oct;67(9-10):334-7.
